Promimic

Promimics nanotechnology, HAnano Surface, creates a unique bioactive surface on any implant. HAnano Surface has demonstrated faster and stronger osseointegration in over 30 clinical studies, with over 1,500,000 clinical applications to date. HAnano Surface is a 20 nanometer thin implant surface modification composed of crystalline hydroxyapatite (HA) particles, which have the same shape, composition, and structure as HA found in human bone. Promimic operates primarily in the United States, Europe, and South America, with current product applications in the dental, spine, total joint, extremities, and sports medicine implant markets. Product Development and Commercialization Partner: Promimic partners with medical device companies...

Osseointegration,nano,bone,hydroxyapatite,hydrophilicity,hydrophilic,bioactive,surface modification,bone growth,dental,orthopedics,osseointegration,and osseointegrate

Promimic operates in the Medical equipment manufacturing industry.

Promimic's revenue is 11m - 100m

Promimic has 11 - 50 employees.